Pontifax Management 4 G.P. (2015) Ltd. insider trades

Open-market stock purchases and sales by Pontifax Management 4 G.P. (2015) Ltd., 10% Owner at Keros Therapeutics, Inc, from SEC Form 4 filings since Mar 21, 2018.

Track record: 11% of 9 scored buys are up 5% or more since purchase, averaging -38%.

Recent trades

DateStockTradeValue
Oct 15, 2025KROS Keros Therapeutics, IncSold$19.9M
Oct 15, 2025KROS Keros Therapeutics, IncSold$21.8M
Oct 15, 2025KROS Keros Therapeutics, IncSold$40.6M
Oct 15, 2025KROS Keros Therapeutics, IncSold$2.8M

Companies traded

  • KROS Keros Therapeutics, Inc: 8 buys, 4 sales, last Oct 15, 2025
  • LBRX LB Pharmaceuticals Inc: 1 buy, last Sep 12, 2025
  • ELOX Eloxx Pharmaceuticals, Inc: 17 buys, last May 13, 2021

Get free alerts when Pontifax Management 4 G.P. (2015) Ltd. files a new trade →